Schistosomiasis.
LoVerde PT.
Adv Exp Med Biol. 2019;1154:45-70. doi: 10.1007/978-3-030-18616-6_3.
Schistosomiasis.
LoVerde PT.
Adv Exp Med Biol. 2024;1454:75-105. doi: 10.1007/978-3-031-60121-7_3.
Research and control of advanced schistosomiasis japonica in China.
Wu W, Feng A, Huang Y.
Parasitol Res. 2015 Jan;114(1):17-27. doi: 10.1007/s00436-014-4225-x. Epub 2014 Nov 19.
The immunobiology of schistosomiasis.
Pearce EJ, MacDonald AS.
Nat Rev Immunol. 2002 Jul;2(7):499-511. doi: 10.1038/nri843.
A Nomogram for Predicting Prognosis of Advanced Schistosomiasis japonica in Dongzhi County-A Case Study.
Hong Z, Zhang S, Li L, Li Y, Liu T, Guo S, Xu X, Yang Z, Zhang H, Xu J.
Trop Med Infect Dis. 2023 Jan 3;8(1):33. doi: 10.3390/tropicalmed8010033.
Potential application of nanotechnology in the treatment, diagnosis, and prevention of schistosomiasis.
Qadeer A, Ullah H, Sohail M, Safi SZ, Rahim A, Saleh TA, Arbab S, Slama P, Horky P.
Front Bioeng Biotechnol. 2022 Dec 9;10:1013354. doi: 10.3389/fbioe.2022.1013354. eCollection 2022.
Vaccine value profile for schistosomiasis.
Yamey G, McDade KK, Anderson RM, Bartsch SM, Bottazzi ME, Diemert D, Hotez PJ, Lee BY, McManus D, Molehin AJ, Roestenberg M, Rollinson D, Siddiqui AA, Tendler M, Webster JP, You H, Zellweger RM, Marshall C.
Vaccine. 2025 Oct 3;64:126020. doi: 10.1016/j.vaccine.2024.05.068. Epub 2024 Jul 23.
Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis.
Ghazy E, Abdelsalam M, Robaa D, Pierce RJ, Sippl W.
Pharmaceuticals (Basel). 2022 Jan 10;15(1):80. doi: 10.3390/ph15010080.
Bladder cancer.
Patton SE, Hall MC, Ozen H.
Curr Opin Oncol. 2002 May;14(3):265-72. doi: 10.1097/00001622-200205000-00003.
Characteristics of peripheral lymphocyte subsets in patients with different stages of schistosomiasis japonica.
Zhou Z, Li J, Jiang J, Luo Y, Yingzi M.
Parasite Immunol. 2023 Oct;45(10):e13006. doi: 10.1111/pim.13006. Epub 2023 Aug 7.
